{"entity":{"type":"insider","cik":"0001327111","url":"/insider/0001327111","json_url":"/insider/0001327111.json","name":"Seely Lynn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":38,"first":"2007-03-20","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Seely Lynn","source":"filing","n_filings":38,"first_seen":"2007-03-20","last_seen":"2026-08-11"}],"transactions":[{"id":9283855,"accession":"0001327111-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001327111-26-000004","line_url":"/filing/0001327111-26-000004#line-1","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":390.0,"shares_display":"390","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":5592.6,"total_display":"5,592.60","total_whole":"5,593","shares_owned_after":73488.0,"shares_owned_after_display":"73,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":5811983,"accession":"0001327111-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001327111-26-000003","line_url":"/filing/0001327111-26-000003#line-1","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":388.0,"shares_display":"388","price_per_share":18.91,"price_display":"18.91","price_state":"stated","total_value":7337.08,"total_display":"7,337.08","total_whole":"7,337","shares_owned_after":73878.0,"shares_owned_after_display":"73,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-06-15","scope":"insider"},{"id":5750923,"accession":"0001327111-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001327111-26-000002","line_url":"/filing/0001327111-26-000002#line-1","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7455.0,"shares_display":"7,455","price_per_share":23.39,"price_display":"23.39","price_state":"stated","total_value":174372.45,"total_display":"174,372.45","total_whole":"174,372","shares_owned_after":74266.0,"shares_owned_after_display":"74,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":6205268,"accession":"0001327111-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001327111-26-000001","line_url":"/filing/0001327111-26-000001#line-2","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":438.0,"shares_display":"438","price_per_share":23.12,"price_display":"23.12","price_state":"stated","total_value":10126.56,"total_display":"10,126.56","total_whole":"10,127","shares_owned_after":81721.0,"shares_owned_after_display":"81,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":4173994,"accession":"0001327111-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001327111-25-000007","line_url":"/filing/0001327111-25-000007#line-1","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":412.0,"shares_display":"412","price_per_share":16.11,"price_display":"16.11","price_state":"stated","total_value":6637.32,"total_display":"6,637.32","total_whole":"6,637","shares_owned_after":67159.0,"shares_owned_after_display":"67,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":5005480,"accession":"0001415889-25-022747","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022747","line_url":"/filing/0001415889-25-022747#line-2","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7257.0,"shares_display":"7,257","price_per_share":10.544,"price_display":"10.54","price_state":"stated","total_value":76517.808,"total_display":"76,517.81","total_whole":"76,518","shares_owned_after":67571.0,"shares_owned_after_display":"67,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":4806844,"accession":"0001415889-25-021694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021694","line_url":"/filing/0001415889-25-021694#line-2","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":406.0,"shares_display":"406","price_per_share":10.338,"price_display":"10.34","price_state":"stated","total_value":4197.228,"total_display":"4,197.23","total_whole":"4,197","shares_owned_after":34828.0,"shares_owned_after_display":"34,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4806838,"accession":"0001415889-25-021694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021694","line_url":"/filing/0001415889-25-021694#line-1","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":391.0,"shares_display":"391","price_per_share":10.526,"price_display":"10.53","price_state":"stated","total_value":4115.666,"total_display":"4,115.67","total_whole":"4,116","shares_owned_after":35234.0,"shares_owned_after_display":"35,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":4683305,"accession":"0001415889-25-008509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008509","line_url":"/filing/0001415889-25-008509#line-1","is_derivative":false,"issuer_cik":"0001327111","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001327111","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":0.6068,"price_display":"0.61","price_state":"stated","total_value":106190.0,"total_display":"106,190.00","total_whole":"106,190","shares_owned_after":712500.0,"shares_owned_after_display":"712,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":6272175,"accession":"0001209191-14-064591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-064591","line_url":"/filing/0001209191-14-064591#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":99.0283,"price_display":"99.03","price_state":"stated","total_value":495141.5,"total_display":"495,141.50","total_whole":"495,142","shares_owned_after":59854.0,"shares_owned_after_display":"59,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-22","filed_date":"2014-10-23","scope":"insider"},{"id":6494321,"accession":"0001209191-14-063842","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-14-063842","line_url":"/filing/0001209191-14-063842#line-9","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":93.97,"price_display":"93.97","price_state":"stated","total_value":469850.0,"total_display":"469,850.00","total_whole":"469,850","shares_owned_after":59854.0,"shares_owned_after_display":"59,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-16","filed_date":"2014-10-17","scope":"insider"},{"id":6494315,"accession":"0001209191-14-063842","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-063842","line_url":"/filing/0001209191-14-063842","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24346.0,"shares_display":"24,346","price_per_share":89.10550891316849,"price_display":"89.11","price_state":"stated","total_value":2169362.72,"total_display":"2,169,362.72","total_whole":"2,169,363","shares_owned_after":68900.0,"shares_owned_after_display":"68,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-15","filed_date":"2014-10-17","scope":"insider","n_lines":4},{"id":7031692,"accession":"0001181431-14-032338","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-14-032338","line_url":"/filing/0001181431-14-032338","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":99.80632,"price_display":"99.81","price_state":"stated","total_value":2495158.0,"total_display":"2,495,158.00","total_whole":"2,495,158","shares_owned_after":66222.0,"shares_owned_after_display":"66,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-18","filed_date":"2014-09-18","scope":"insider","n_lines":2},{"id":7031686,"accession":"0001181431-14-032338","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-032338","line_url":"/filing/0001181431-14-032338","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":97.35756666666667,"price_display":"97.36","price_state":"stated","total_value":2920727.0,"total_display":"2,920,727.00","total_whole":"2,920,727","shares_owned_after":62422.0,"shares_owned_after_display":"62,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-17","filed_date":"2014-09-18","scope":"insider","n_lines":3},{"id":6940965,"accession":"0001181431-14-031780","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-031780","line_url":"/filing/0001181431-14-031780","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":94.600797,"price_display":"94.60","price_state":"stated","total_value":1892015.94,"total_display":"1,892,015.94","total_whole":"1,892,016","shares_owned_after":64209.0,"shares_owned_after_display":"64,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-11","scope":"insider","n_lines":2},{"id":6610426,"accession":"0001181431-14-030477","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-030477","line_url":"/filing/0001181431-14-030477","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14300.0,"shares_display":"14,300","price_per_share":89.61,"price_display":"89.61","price_state":"stated","total_value":1281423.0,"total_display":"1,281,423.00","total_whole":"1,281,423","shares_owned_after":61622.0,"shares_owned_after_display":"61,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-28","scope":"insider","n_lines":2},{"id":6610417,"accession":"0001181431-14-030477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-030477","line_url":"/filing/0001181431-14-030477#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":88.953,"price_display":"88.95","price_state":"stated","total_value":507032.1,"total_display":"507,032.10","total_whole":"507,032","shares_owned_after":59022.0,"shares_owned_after_display":"59,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-26","filed_date":"2014-08-28","scope":"insider"},{"id":6490356,"accession":"0001181431-14-029265","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-029265","line_url":"/filing/0001181431-14-029265","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":83.6228,"price_display":"83.62","price_state":"stated","total_value":1672456.0,"total_display":"1,672,456.00","total_whole":"1,672,456","shares_owned_after":68022.0,"shares_owned_after_display":"68,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-14","scope":"insider","n_lines":3},{"id":6553957,"accession":"0001181431-14-029026","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-14-029026","line_url":"/filing/0001181431-14-029026#line-7","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":84.01,"price_display":"84.01","price_state":"stated","total_value":1050125.0,"total_display":"1,050,125.00","total_whole":"1,050,125","shares_owned_after":59022.0,"shares_owned_after_display":"59,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-12","scope":"insider"},{"id":6553953,"accession":"0001181431-14-029026","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-029026","line_url":"/filing/0001181431-14-029026","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":82.06315384615385,"price_display":"82.06","price_state":"stated","total_value":1066821.0,"total_display":"1,066,821.00","total_whole":"1,066,821","shares_owned_after":67722.0,"shares_owned_after_display":"67,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-08","filed_date":"2014-08-12","scope":"insider","n_lines":4},{"id":6585028,"accession":"0001181431-14-027262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-027262","line_url":"/filing/0001181431-14-027262#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":73.9613,"price_display":"73.96","price_state":"stated","total_value":554709.75,"total_display":"554,709.75","total_whole":"554,710","shares_owned_after":59022.0,"shares_owned_after_display":"59,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-22","filed_date":"2014-07-23","scope":"insider"},{"id":6553805,"accession":"0001181431-14-026394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-026394","line_url":"/filing/0001181431-14-026394#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":79.0162,"price_display":"79.02","price_state":"stated","total_value":948194.4,"total_display":"948,194.40","total_whole":"948,194","shares_owned_after":59022.0,"shares_owned_after_display":"59,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2014-07-07","scope":"insider"},{"id":6723113,"accession":"0001181431-14-024511","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-024511","line_url":"/filing/0001181431-14-024511","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":75.004,"price_display":"75.00","price_state":"stated","total_value":562530.0,"total_display":"562,530.00","total_whole":"562,530","shares_owned_after":61022.0,"shares_owned_after_display":"61,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-18","filed_date":"2014-06-19","scope":"insider","n_lines":2},{"id":6723105,"accession":"0001181431-14-024511","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-024511","line_url":"/filing/0001181431-14-024511","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":74.50133333333333,"price_display":"74.50","price_state":"stated","total_value":558760.0,"total_display":"558,760.00","total_whole":"558,760","shares_owned_after":60022.0,"shares_owned_after_display":"60,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-19","scope":"insider","n_lines":2},{"id":3439329,"accession":"0001181431-12-042507","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-12-042507","line_url":"/filing/0001181431-12-042507","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37600.0,"shares_display":"37,600","price_per_share":99.72913841489361,"price_display":"99.73","price_state":"stated","total_value":3749815.6044,"total_display":"3,749,815.60","total_whole":"3,749,816","shares_owned_after":27017.0,"shares_owned_after_display":"27,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-26","filed_date":"2012-07-27","scope":"insider","n_lines":2},{"id":3439325,"accession":"0001181431-12-042507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-042507","line_url":"/filing/0001181431-12-042507#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":98.0077,"price_display":"98.01","price_state":"stated","total_value":235218.48,"total_display":"235,218.48","total_whole":"235,218","shares_owned_after":21511.0,"shares_owned_after_display":"21,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-25","filed_date":"2012-07-27","scope":"insider"},{"id":2806397,"accession":"0001181431-12-032552","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-032552","line_url":"/filing/0001181431-12-032552#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":88.5067,"price_display":"88.51","price_state":"stated","total_value":1106333.75,"total_display":"1,106,333.75","total_whole":"1,106,334","shares_owned_after":21511.0,"shares_owned_after_display":"21,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-22","filed_date":"2012-05-24","scope":"insider"},{"id":2389002,"accession":"0001181431-12-031386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-031386","line_url":"/filing/0001181431-12-031386#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14360.0,"shares_display":"14,360","price_per_share":88.0104,"price_display":"88.01","price_state":"stated","total_value":1263829.344,"total_display":"1,263,829.34","total_whole":"1,263,829","shares_owned_after":21511.0,"shares_owned_after_display":"21,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-17","filed_date":"2012-05-21","scope":"insider"},{"id":2729491,"accession":"0001181431-12-030354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-030354","line_url":"/filing/0001181431-12-030354#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35640.0,"shares_display":"35,640","price_per_share":88.076,"price_display":"88.08","price_state":"stated","total_value":3139028.64,"total_display":"3,139,028.64","total_whole":"3,139,029","shares_owned_after":21511.0,"shares_owned_after_display":"21,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-14","filed_date":"2012-05-16","scope":"insider"},{"id":2299748,"accession":"0001181431-12-016440","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-12-016440","line_url":"/filing/0001181431-12-016440","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71555.0,"shares_display":"71,555","price_per_share":70.10896345468521,"price_display":"70.11","price_state":"stated","total_value":5016646.88,"total_display":"5,016,646.88","total_whole":"5,016,647","shares_owned_after":79783.0,"shares_owned_after_display":"79,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-08","filed_date":"2012-03-12","scope":"insider","n_lines":2},{"id":9178426,"accession":"0001181431-11-018752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-018752","line_url":"/filing/0001181431-11-018752#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.4777,"price_display":"16.48","price_state":"stated","total_value":823885.0,"total_display":"823,885.00","total_whole":"823,885","shares_owned_after":16666.0,"shares_owned_after_display":"16,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-15","filed_date":"2011-03-17","scope":"insider"},{"id":9043617,"accession":"0001181431-11-010890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-010890","line_url":"/filing/0001181431-11-010890#line-2","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":17.9664,"price_display":"17.97","price_state":"stated","total_value":898320.0,"total_display":"898,320.00","total_whole":"898,320","shares_owned_after":16666.0,"shares_owned_after_display":"16,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-15","filed_date":"2011-02-16","scope":"insider"},{"id":8985140,"accession":"0001181431-11-004551","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-11-004551","line_url":"/filing/0001181431-11-004551#line-4","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001327111","owner_name":"Seely Lynn","owner_display_name":"Seely Lynn","owner_url":"/insider/0001327111","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":14.4485,"price_display":"14.45","price_state":"stated","total_value":361212.5,"total_display":"361,212.50","total_whole":"361,213","shares_owned_after":16666.0,"shares_owned_after_display":"16,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-19","filed_date":"2011-01-20","scope":"insider"}],"collapsed":true,"next_cursor":"2011-01-19|8985140","ledger_fault":false,"count":{"value":67,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":66,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":67},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806952","name":"Lyell Immunopharma, Inc.","url":"/issuer/0001806952","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2025-03-18","last_seen":"2026-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001011835","name":"MEDIVATION, INC.","url":"/issuer/0001011835","role":"Officer (Chief Medical Officer)","n_filings":30,"first_seen":"2007-03-20","last_seen":"2014-10-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001327111","retrieved_at":"2026-08-24T09:31:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}